Targeting the mTOR Signaling Pathway Utilizing Nanoparticles: A Critical Overview

Proteins of the mammalian target of rapamycin (mTOR) signaling axis are overexpressed or mutated in cancers. However, clinical inhibition of mTOR signaling as a therapeutic strategy in oncology shows rather limited progress. Nanoparticle-based mTOR targeted therapy proposes an attractive therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunova, Mariia, Smolková, Barbora, Lynnyk, Anna, Uzhytchak, Mariia, Jirsa, Milan, Kubinová, Šárka, Dejneka, Alexandr, Lunov, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356373/
https://www.ncbi.nlm.nih.gov/pubmed/30642006
http://dx.doi.org/10.3390/cancers11010082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356373/
https://www.ncbi.nlm.nih.gov/pubmed/30642006
http://dx.doi.org/10.3390/cancers11010082

Ejemplares similares